168P Response assessments in hepatocellular carcinoma: What are the best criteria to utilize? mRECIST or RECIST 1.1? A retrospective meta-analysis of multiple phase III trials
作者
Oliver Bohnsack,M. Lesch,Jayant Narang,Surabhi Bajpai,Riccardo Lencioni
出处
期刊:Annals of Oncology [Elsevier BV] 日期:2020-11-01卷期号:31: S1304-S1304被引量:1